Marcelo Kremenchutzky

Deficient MWF mapping in multiple sclerosis using 3D whole-brain multi-component relaxation MRI

Brian K. Rutt, Jason Su, Hagen H. Kitzler, 2012, NeuroImage.

Venocentric Lesions: An MRI Marker of MS?

Ravi S. Menon, Marcelo Kremenchutzky, M. Kremenchutzky, 2013, Front. Neurol..

Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring

Ludwig Kappos, Jan Hillert, Gilles Edan, 2007, The Lancet Neurology.

Multiple sclerosis: improved identification of disease-relevant changes in gray and white matter by using susceptibility-based MR imaging.

Ravi S. Menon, Ravi S Menon, Joseph S Gati, 2014, Radiology.

Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b

Dawn Langdon, Anthony L Traboulsee, Marcelo Kremenchutzky, 2019, Multiple sclerosis.

Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: a randomized, placebo-controlled, multiple-dose study.

Marcelo Kremenchutzky, Adam Carpenter, A. Carpenter, 2014, Multiple sclerosis and related disorders.

The safety and efficacy of IFN-β products for the treatment of multiple sclerosis

Sarah Morrow, Marcelo Kremenchutzky, S. Morrow, 2007 .

Autonomic dysfunction in multiple sclerosis

Marcelo Kremenchutzky, S. Morrow, M. Kremenchutzky, 2015, Autonomic Neuroscience.